Showing results (71-80 of 395) with videos related to

Sort By:
Pageof 40
Haematologica|November 1, 1996
Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemiaE Zuffa, N Vianelli, G Martinelli, et al.
Leukemia|November 1, 1992
Biological markers and minimal residual disease in hairy cell leukemiaF Lauria, D Raspadori, D Benfenati, et al.
Experimental Hematology|June 1, 1994
Limiting dilution analysis of a novel tripeptide anticancer agent Ambamustine (PTT-119): effect on K-562, CCRF-SB and multidrug resistant LoVo-Dk cell linesA Manna, A Porcellini, G Visani, et al.
Haematologica|May 1, 1997
The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory casesG Visani, E Ottaviani, M Danova, et al.
Seminars in Oncology|December 1, 1990
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histologyF Gherlinzoni, C Guglielmi, P Mazza, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Immunological markers in non-Hodgkin's lymphomasM Gobbi, P Mazza, W Mantovani, et al.
Haematologica|December 29, 1998
Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remissionE Ottaviani, G Martinelli, N Testoni, et al.
Haematologica|November 24, 1998
Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular levelG Martinelli, E Ottaviani, G Visani, et al.
American Journal of Hematology|November 26, 1997
Reduction of heat-shock protein-70 after prolonged treatment with retinoids: biological and clinical implicationsP Tosi, G Visani, E Ottaviani, et al.
Haematologica|March 1, 1996
All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease associationG Visani, G Bontempo, S Manfroi, et al.
Pageof 40